CuraGenex drives Saudi Arabia's leadership in biotechnology and genomics.
Inspired by the National Biotechnology Strategy and fully aligned with Vision 2030, CuraGenex was founded to help shape a future where genomics is embedded at the heart of healthcare, research, and innovation in the Kingdom.
Our mission is to contribute to a healthcare system that is predictive rather than reactive, personalized rather than generalized, and innovation-driven rather than technology-dependent.
Comprehensive Genomic Capabilities
Through its fully integrated genomic infrastructure,
CuraGenex provides an
end-to-end portfolio of advanced services
across testing, analysis,
interpretation, and clinical support.
Clinical Genetic Testing
Clinical genetic testing analyzes an individual's DNA to identify genetic variations that may affect their health. Supporting accurate diagnosis, guiding treatment decisions, and enabling personalized care plans.
Bioinformatics Services
Bioinformatics and Reporting Services is an advanced clinical interpretation solution , transforming raw NGS, WES, or WGS data into clear, actionable clinical reports. Bridging the gap between complex genomic data and real-world decision making.
Sequencing Services
CuraGenex Sequencing Services provides high-quality raw genomic data ( FASQ, BAM, VCF files) for healthcare professionals and research teams who handle their own interpretation. it delivers reliable, clinical-grade sequence output with comprehensive QC metrics powering downstream analysis and discovery
Whole-Exome Sequencing (WES)
Whole-exome sequencing focuses on the protein-coding regions of the genome, where most disease-causing variants occur, providing high-resolution insights into genetic variants.
Whole-Genome Sequencing (WGS)
Whole-genome sequencing analyzes the entire DNA sequence, including coding and non-coding regions, offering the most complete view of an individual's genetic profile.
Molecular Assays
Molecular Assays deliver precise, clinical-grade result from Sanger sequencing and MLPA for healthcare professionals and research teams targeting specific mutations or copy number variants.
Investment in National Genomic Infrastructure
Designed in alignment with the national biotechnology and genomics strategy, CuraGenex has committed significant long-term resources to build sovereign infrastructure rather than short-term testing services.
Advanced Laboratory
Infrastructure
Our advanced laboratory infrastructure is purpose-built for high-throughput genetic testing, centered around an Illumina
Novaseq X plus platform to deliver scalable, clinical-grade genomics.
Secure In-Country Data
Platforms
Our on-site secure computing environment is engineered for large-scale sequence data processing. This architecture enables us to balance routine clinical operations with ongoing innovation and future capability development, ensuring that our infrastructure can adapt as precision medicine advances.
Specialized Scientific
Leadership
Our company is led by scientific experts with expertise in genomics and molecular diagnostics. Our experienced PhD-level scientists ensure every service—from customer service to sequencing and interpretation—delivers precision, reliability, and cutting-edge insights for healthcare and research excellence.
Advanced Bioinformatics
Pipeline
Our advanced NGS bioinformatics pipeline transforms raw sequence data into clinician-ready insights through a fully validated, end-to-end workflow optimized for clinical-grade exome, genome, and targeted sequencing.
Contact us
Have questions about our genomic solutions or interested in a partnership? Our team of experts is ready to assist you.